Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

894
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
894
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors01:19

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

166
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
166
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

243
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
243
Hormonal Control of the Ovarian Cycle01:30

Hormonal Control of the Ovarian Cycle

438
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle.  At puberty, GnRH secretion increases in both frequency and...
438
Overview of Carbohydrate Metabolism01:19

Overview of Carbohydrate Metabolism

776
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
776

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Improvement of Mouse Spermatozoa Freezing at -80°C With Ascorbic Acid 2-Glucoside at Thawing Phase.

Andrology·2026
Same author

Unraveling the Effects of Freezing and Frozen Storage Temperatures on Hop Secondary Metabolites and Antioxidants.

Antioxidants (Basel, Switzerland)·2026
Same author

Immuno-Instructive 3D Tendon Biomimetic Scaffolds Functionalized with Amniotic Epithelial Stem Cell Secretome for Controlled Inflammation and Targeted Macrophage Polarization.

International journal of molecular sciences·2026
Same author

From -196°C to -80°C: redefining standards in sperm biobanking technology.

Reproductive biomedicine online·2025
Same author

Neural Markers Predict Tendon Healing Outcomes in an Ovine Achilles Tendon Injury Model: Spontaneous Repair Versus Amniotic Epithelial Cell-Induced Regeneration.

International journal of molecular sciences·2025
Same author

Exposure to Polystyrene Microplastic Differentially Affects the Colon and Liver in Adult Male Mice.

Environmental toxicology·2025

Related Experiment Video

Updated: Jun 11, 2025

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model
09:44

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model

Published on: March 5, 2022

2.9K

Navigating the Intersection of Glycemic Control and Fertility: A Network Perspective.

Carlo Di Carlo1, Costanza Cimini1, Ramses Belda-Perez1,2

  • 1Department of Biosciences and Technology for Food, Agriculture and Environment, University of Teramo, 64100 Teramo, Italy.

International Journal of Molecular Sciences
|September 28, 2024
PubMed
Summary

High blood glucose and resulting advanced glycation end products (AGEs) impact fertility. A network model reveals AGEs affect sperm TRPV1 receptors and suggests immune cells may clear AGEs, linking metabolic health, immunity, and reproductive function.

Keywords:
advanced glycation end productsbiological networkglycemic controlimmunityinfertilityreproductionsystem biology

More Related Videos

Author Spotlight: Exploring the Long-Term Health Impacts of Intracytoplasmic Sperm Injection on Offspring
06:11

Author Spotlight: Exploring the Long-Term Health Impacts of Intracytoplasmic Sperm Injection on Offspring

Published on: May 17, 2024

517
Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

18.8K

Related Experiment Videos

Last Updated: Jun 11, 2025

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model
09:44

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model

Published on: March 5, 2022

2.9K
Author Spotlight: Exploring the Long-Term Health Impacts of Intracytoplasmic Sperm Injection on Offspring
06:11

Author Spotlight: Exploring the Long-Term Health Impacts of Intracytoplasmic Sperm Injection on Offspring

Published on: May 17, 2024

517
Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

18.8K

Area of Science:

  • Metabolic disease research
  • Reproductive biology
  • Immunology

Background:

  • Elevated blood glucose contributes to metabolic diseases like diabetes and advanced glycation end product (AGE) accumulation.
  • AGEs, formed from sugar-protein reactions, deposit in tissues and are linked to various pathologies.
  • Understanding the link between glycemic control, AGEs, and health outcomes is crucial.

Purpose of the Study:

  • To explore the relationship between glycemic control and AGE accumulation.
  • To investigate the implications of AGEs on fertility.
  • To identify key molecular players and pathways involved in these processes.

Main Methods:

  • Development of a computational network model using network theory.
  • Inclusion of a molecular database within a Barabasi-Albert scale-free network (145 nodes, 262 links).
  • Analysis of node subsets related to glycemic control, fertility, and immunity.

Main Results:

  • Advanced glycation end products (AGEs) were identified as a critical factor connecting glycemic control, fertility, and immunity.
  • The transient receptor potential vanilloid 1 (TRPV1) receptor in sperm was highlighted as a key hub, potentially modulated by AGEs, affecting fertility.
  • A novel connection was established between glycemic control and immunity, with evidence suggesting immune cells can endocytose specific AGEs.

Conclusions:

  • Glycemic control significantly influences AGE accumulation, impacting fertility through mechanisms like TRPV1 modulation in sperm.
  • Immune cells may play a role in AGE clearance, indicating a complex interplay between metabolic and immune systems.
  • These findings have broad implications for understanding and managing metabolic diseases, immune function, and fertility.